Retroperitoneal Sarcoma Clinical Trials

9 recruiting

Retroperitoneal Sarcoma Trials at a Glance

9 actively recruiting trials for retroperitoneal sarcoma are listed on ClinicalTrialsFinder across 6 cities in 18 countries. The largest study group is Phase 1 with 4 trials, with the heaviest enrollment activity in Boston, Chicago, and London. Lead sponsors running retroperitoneal sarcoma studies include Cancer Institute and Hospital, Chinese Academy of Medical Sciences, European Organisation for Research and Treatment of Cancer - EORTC, and Brigham and Women's Hospital.

Browse retroperitoneal sarcoma trials by phase

Treatments under study

About Retroperitoneal Sarcoma Clinical Trials

Looking for clinical trials for Retroperitoneal Sarcoma? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Retroperitoneal Sarcoma trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Retroperitoneal Sarcoma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

Liver CancerMelanomaMerkel Cell Carcinoma+9 more
Istituto Oncologico Veneto IRCCS24 enrolled1 locationNCT06753136
Recruiting
Phase 3

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

LeiomyosarcomaRetroperitoneal SarcomaLiposarcoma
European Organisation for Research and Treatment of Cancer - EORTC250 enrolled164 locationsNCT04031677
Recruiting
Phase 1

Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma

Retroperitoneal Sarcoma
University of Washington18 enrolled1 locationNCT06025747
Recruiting
Phase 1Phase 2

Proton or Photon RT for Retroperitoneal Sarcomas

Retroperitoneal Sarcoma
Massachusetts General Hospital80 enrolled10 locationsNCT01659203
Recruiting

Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients

SarcomaAngiosarcomaSoft Tissue Sarcoma (STS)+9 more
Royal Marsden NHS Foundation Trust800 enrolled1 locationNCT07432932
Recruiting
Not Applicable

Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma (FUSION-01)

Radiotherapy Side EffectSoft Tissue SarcomaRetroperitoneal Sarcoma+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences50 enrolled1 locationNCT05224934
Recruiting
Phase 1Phase 2

Proton-Spatially Fractionated Radiotherapy and Standard Radiation Therapy for the Treatment of Newly Diagnosed Retroperitoneal Soft Tissue Sarcoma

Retroperitoneal Sarcoma
Northwestern University28 enrolled1 locationNCT06327477
Recruiting
Phase 1

Short Course Radiation Treatment for Patients With Primary or Locally Recurrent Retroperitoneal Sarcoma Prior to Surgery

Retroperitoneal Sarcoma
Brigham and Women's Hospital6 enrolled1 locationNCT06812052
Recruiting

REtroperitoneal SArcoma Registry: an International Prospective Initiative

Retroperitoneal Sarcoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano2,000 enrolled22 locationsNCT03838718